Aim: Research has revealed higher risks of somatic problems among patients with non-affective psychotic disorders (NAPD) compared to the general population. The aim of this study was to examine whether NAPD patients also show increased somatic health care utilization compared to personally-matched controls without a psychiatric diagnosis and patients with unipolar depression, anxiety disorder or bipolar disorder. Methods: Data from a large Health Insurance agency were used to analyze prescribed somatic medication, general practitioner consultations, and treatment by a somatic specialist. Results: Patients with NAPD showed serious somatic under treatment, which was associated with older age and longer illness duration. Conclusion: In view of the high risk on natural death causes among patients with NAPD, our data indicate under treatment for physical disorders, especially at older age and with longer duration of the mental disorder. Presentatie voor UMCU Psychiatrie All-in 24 oktober 2017
From Narcis.nl :" Patients with substance use disorder (SUD) are frequently suffering from co-occurring somatic disorders, increasing the risk of mortality. Somatic health care utilization (sHCU) often remains unknown to the physician during SUD treatment. This paper analyses sHCU and associated costs among patients in SUD treatment compared to matched, non-substance dependent controls. METHODS: Health care utilization data on 4972 SUD patients were matched to 19,846 controls by gender, birth year and ethnic origin. Subcategories of patients were formed based on SUD and on co-morbid psychiatric disorder. Data on sHCU during the year prior to the last treatment contact (the 'index date') for both patients and their matched controls were extracted from a health insurance database. RESULTS: Patients had a higher sHCU (with increased associated costs) than controls, especially when alcohol dependence was involved. In particular, sHCU for cardiovascular, respiratory, infectious diseases, injuries and accidents was increased among patients. However, the use of preventive medication, such as lipid-lowering drugs, is lower among SUD patients. Co-morbidity of psychiatric disorders led to further increase of sHCU, whereas patients with comorbid non-affective psychotic disorder (NAPD) showed lower sHCU and costs. CONCLUSION: Patients with SUD overall have a high sHCU, associated with high costs. There are indications that SUD patients have less access to preventive medication. Patients with comorbid NAPD are at risk of possible underutilization of somatic health care. Furthermore, we conclude that these larger administrative databases allow for comparisons between various diagnostic categories."
MULTIFILE
Aim: Research has revealed higher risks of somatic problems among patients with non-affective psychotic disorders (NAPD) compared to the general population. The aim of this study was to examine whether NAPD patients also show increased somatic health care utilization compared to personally-matched controls without a psychiatric diagnosis and patients with unipolar depression, anxiety disorder or bipolar disorder. Methods: Data from a large Health Insurance agency were used to analyze prescribed somatic medication, general practitioner consultations, and treatment by a somatic specialist. Results: Patients with NAPD showed serious somatic under treatment, which was associated with older age and longer illness duration. Conclusion: In view of the high risk on natural death causes among patients with NAPD, our data indicate under treatment for physical disorders, especially at older age and with longer duration of the mental disorder.
